{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:55:03Z","timestamp":1762509303095,"version":"3.44.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,22]]},"DOI":"10.7759\/cureus.92966","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:30:41Z","timestamp":1758583841000},"source":"Crossref","is-referenced-by-count":1,"title":["Severe Toxicities From Definitive Chemoradiotherapy for Oropharyngeal Cancer in a Patient With Comorbid Sj\u00f6gren\u2019s Syndrome"],"prefix":"10.7759","author":[{"given":"Mitsutoshi","family":"Ooishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Togao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichiro","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"5","year":"2023","unstructured":"Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050. a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023, 5:e594-610. 10.1016\/S2665-9913(23)00211-4","journal-title":"Lancet Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.04.009","article-title":"Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment","volume":"203","author":"Vivino FB","year":"2019","unstructured":"Vivino FB, Bunya VY, Massaro-Giordano G, et al.. Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment. Clin Immunol. 2019, 203:81-121. 10.1016\/j.clim.2019.04.009","journal-title":"Clin Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2013.843765","article-title":"Primary and secondary surveys on epidemiology of Sj\u00f6gren's syndrome in Japan","volume":"24","author":"Tsuboi H","year":"2014","unstructured":"Tsuboi H, Asashima H, Takai C, et al.. Primary and secondary surveys on epidemiology of Sj\u00f6gren's syndrome in Japan. Mod Rheumatol. 2014, 24:464-70. 10.3109\/14397595.2013.843765","journal-title":"Mod Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200108023450506","article-title":"Autoimmune diseases","volume":"345","author":"Davidson A","year":"2001","unstructured":"Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001, 345:340-50. 10.1056\/NEJM200108023450506","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102882","article-title":"Autoimmunity and cancer","volume":"20","author":"Masetti R","year":"2021","unstructured":"Masetti R, Tiri A, Tignanelli A, Turrini E, Argentiero A, Pession A, Esposito S. Autoimmunity and cancer. Autoimmun Rev. 2021, 20:102882. 10.1016\/j.autrev.2021.102882","journal-title":"Autoimmun Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli A","year":"2009","unstructured":"Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009, 360:1989-2003. 10.1056\/NEJMra0806188","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103084","article-title":"Primary Sj\u00f6gren's syndrome is associated with increased risk of malignancies besides lymphoma: a systematic review and meta-analysis","volume":"21","author":"Zhong H","year":"2022","unstructured":"Zhong H, Liu S, Wang Y, Xu D, Li M, Zhao Y, Zeng X. Primary Sj\u00f6gren's syndrome is associated with increased risk of malignancies besides lymphoma: a systematic review and meta-analysis. Autoimmun Rev. 2022, 21:103084. 10.1016\/j.autrev.2022.103084","journal-title":"Autoimmun Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2021.08.006","article-title":"Radiation toxicity in patients with collagen vascular disease: a meta-analysis of case-control studies","volume":"111","author":"Shaikh PM","year":"2021","unstructured":"Shaikh PM, Singh SA, Alite F, et al.. Radiation toxicity in patients with collagen vascular disease: a meta-analysis of case-control studies. Int J Radiat Oncol Biol Phys. 2021, 111:1214-26. 10.1016\/j.ijrobp.2021.08.006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2010.08.030","article-title":"Collagen vascular diseases and enhanced radiotherapy-induced normal tissue effects--a case report and a review of published studies","volume":"23","author":"Lee CE","year":"2011","unstructured":"Lee CE, Prabhu V, Slevin NJ. Collagen vascular diseases and enhanced radiotherapy-induced normal tissue effects--a case report and a review of published studies. Clin Oncol (R Coll Radiol). 2011, 23:73-8. 10.1016\/j.clon.2010.08.030","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref10","article-title":"","year":"2016","unstructured":"TNM Classification of Malignant Tumours, 8th edition. Brierley JD (ed). Union for International Cancer Control, Geneva, Switzerland; 2016. https:\/\/www.uicc.org\/resources\/tnm-classification-malignant-tumours-8th-edition."},{"key":"ref11","article-title":"","year":"2017","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. Brierley JD (ed). US Department for Health and Human Services, Washington, D.C.; 2017. https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v5-5x7.pdf."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23591","article-title":"Toxicity of radiotherapy in patients with collagen vascular disease","volume":"113","author":"Lin A","year":"2008","unstructured":"Lin A, Abu-Isa E, Griffith KA, Ben-Josef E. Toxicity of radiotherapy in patients with collagen vascular disease. Cancer. 2008, 113:648-53. 10.1002\/cncr.23591","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/401825","article-title":"Head and neck cancer with dermatomyositis: a report of two clinical cases","volume":"2010","author":"Yamauchi K","year":"2010","unstructured":"Yamauchi K, Kogashiwa Y, Nagafuji H, Kohno N. Head and neck cancer with dermatomyositis: a report of two clinical cases. Int J Otolaryngol. 2010, 2010:401825. 10.1155\/2010\/401825","journal-title":"Int J Otolaryngol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3109\/00016489.2014.913312","article-title":"Paired study of 172 cases of nasopharyngeal carcinoma with or without dermatomyositis","volume":"134","author":"Huang PY","year":"2014","unstructured":"Huang PY, Zhong ZL, Luo DH, et al.. Paired study of 172 cases of nasopharyngeal carcinoma with or without dermatomyositis. Acta Otolaryngol. 2014, 134:824-30. 10.3109\/00016489.2014.913312","journal-title":"Acta Otolaryngol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison ML","year":"2019","unstructured":"Gillison ML, Trotti AM, Harris J, et al.. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet. 2019, 393:40-50. 10.1016\/S0140-6736(18)32779-X","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jjco.a023206","article-title":"Retropharyngeal abscess after radiation therapy and cis-platinum, 5-fluorouracil treatment for nasopharyngeal carcinoma with collagen disease: report of two patients and a review of the literature","volume":"26","author":"Hareyama M","year":"1996","unstructured":"Hareyama M, Nagakura H, Tamakawa M, et al.. Retropharyngeal abscess after radiation therapy and cis-platinum, 5-fluorouracil treatment for nasopharyngeal carcinoma with collagen disease: report of two patients and a review of the literature. Jpn J Clin Oncol. 1996, 26:189-93. 10.1093\/oxfordjournals.jjco.a023206","journal-title":"Jpn J Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/01.coc.0000239164.01855.50","article-title":"Severe acute toxicity from whole breast radiotherapy in the setting of collagen vascular disease","volume":"29","author":"Hernandez S","year":"2006","unstructured":"Hernandez S, Evans SB, Wazer DE. Severe acute toxicity from whole breast radiotherapy in the setting of collagen vascular disease. Am J Clin Oncol. 2006, 29:647-8. 10.1097\/01.coc.0000239164.01855.50","journal-title":"Am J Clin Oncol"},{"key":"ref18","article-title":"Unusual cancer in primary Sj\u00f6gren syndrome","volume":"60","author":"Lai WS","year":"2014","unstructured":"Lai WS, Liu FC, Wang CH, Chen HC. Unusual cancer in primary Sj\u00f6gren syndrome. Can Fam Physician. 2014, 60:912-5.","journal-title":"Can Fam Physician"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2017.10.002","article-title":"Radiation toxicity in patients with collagen vascular disease and intrathoracic malignancy treated with modern radiation techniques","volume":"125","author":"Diao K","year":"2017","unstructured":"Diao K, Chen YH, Catalano PJ, et al.. Radiation toxicity in patients with collagen vascular disease and intrathoracic malignancy treated with modern radiation techniques. Radiother Oncol. 2017, 125:301-9. 10.1016\/j.radonc.2017.10.002","journal-title":"Radiother Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.10.014","article-title":"Systemic lupus erythematosus, radiotherapy, and the risk of acute and chronic toxicity: the Mayo Clinic Experience","volume":"71","author":"Pinn ME","year":"2008","unstructured":"Pinn ME, Gold DG, Petersen IA, Osborn TG, Brown PD, Miller RC. Systemic lupus erythematosus, radiotherapy, and the risk of acute and chronic toxicity: the Mayo Clinic Experience. Int J Radiat Oncol Biol Phys. 2008, 71:498-506. 10.1016\/j.ijrobp.2007.10.014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2024.04.015","article-title":"The impact of radiation therapy in patients with systemic sclerosis and head and neck cancer","volume":"14","author":"Wallwork RS","year":"2024","unstructured":"Wallwork RS, Page BR, Wigley FM, et al.. The impact of radiation therapy in patients with systemic sclerosis and head and neck cancer. Pract Radiat Oncol. 2024, 14:e334-43. 10.1016\/j.prro.2024.04.015","journal-title":"Pract Radiat Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1177\/23247096231168114","article-title":"Radiation recall dermatitis following treatment with pembrolizumab: a case report and review of the literature","volume":"11","author":"Sandhu M","year":"2023","unstructured":"Sandhu M, Ashok Kumar P, Deck J, Zerdan MB, Lacombe M, Sivapiragasam A. Radiation recall dermatitis following treatment with pembrolizumab: a case report and review of the literature. J Investig Med High Impact Case Rep. 2023, 11:23247096231168114. 10.1177\/23247096231168114","journal-title":"J Investig Med High Impact Case Rep"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-023-02059-9","article-title":"Recognizing cisplatin as a\u00a0potential radiation recall trigger: case report and focused systematic review","volume":"199","author":"Tamaskovics B","year":"2023","unstructured":"Tamaskovics B, Haussmann J, Karimi K, et al.. Recognizing cisplatin as a\u00a0potential radiation recall trigger: case report and focused systematic review. Strahlenther Onkol. 2023, 199:611-20. 10.1007\/s00066-023-02059-9","journal-title":"Strahlenther Onkol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2022.04.001","article-title":"Radiation recall dermatitis: a review of the literature","volume":"49","author":"Bhangoo RS","year":"2022","unstructured":"Bhangoo RS, Cheng TW, Petersen MM, et al.. Radiation recall dermatitis: a review of the literature. Semin Oncol. 2022, 49:152-9. 10.1053\/j.seminoncol.2022.04.001","journal-title":"Semin Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206008","article-title":"Defining disease activity states and clinically meaningful improvement in primary Sj\u00f6gren's syndrome with EULAR primary Sj\u00f6gren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)","volume":"75","author":"Seror R","year":"2016","unstructured":"Seror R, Bootsma H, Saraux A, et al.. Defining disease activity states and clinically meaningful improvement in primary Sj\u00f6gren's syndrome with EULAR primary Sj\u00f6gren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Ann Rheum Dis. 2016, 75:382-9. 10.1136\/annrheumdis-2014-206008","journal-title":"Ann Rheum Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2014-000022","article-title":"EULAR Sj\u00f6gren's syndrome disease activity index (ESSDAI): a user guide","volume":"1","author":"Seror R","year":"2015","unstructured":"Seror R, Bowman SJ, Brito-Zeron P, et al.. EULAR Sj\u00f6gren's syndrome disease activity index (ESSDAI): a user guide. RMD Open. 2015, 1:e000022. 10.1136\/rmdopen-2014-000022","journal-title":"RMD Open"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2025.01.004","article-title":"De-escalated management of HPV-positive oropharyngeal carcinoma: Improving outcomes with personalized approaches","volume":"35","author":"Yacoub I","year":"2025","unstructured":"Yacoub I, Shamseddine A, Qian J, Youssef M, Safavi AH, Lee NY. De-escalated management of HPV-positive oropharyngeal carcinoma: Improving outcomes with personalized approaches. Semin Radiat Oncol. 2025, 35:157-65. 10.1016\/j.semradonc.2025.01.004","journal-title":"Semin Radiat Oncol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-05077-5","article-title":"Radiotherapy-related quality of life in patients with head and neck cancers: a meta-analysis","volume":"28","author":"Ge X","year":"2020","unstructured":"Ge X, Liao Z, Yuan J, et al.. Radiotherapy-related quality of life in patients with head and neck cancers: a meta-analysis. Support Care Cancer. 2020, 28:2701-12. 10.1007\/s00520-019-05077-5","journal-title":"Support Care Cancer"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S47399","article-title":"The epidemiology of Sj\u00f6gren's syndrome","volume":"6","author":"Patel R","year":"2014","unstructured":"Patel R, Shahane A. The epidemiology of Sj\u00f6gren's syndrome. Clin Epidemiol. 2014, 6:247-55. 10.2147\/CLEP.S47399","journal-title":"Clin Epidemiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/407303-severe-toxicities-from-definitive-chemoradiotherapy-for-oropharyngeal-cancer-in-a-patient-with-comorbid-sjgrens-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:30:47Z","timestamp":1758583847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/407303-severe-toxicities-from-definitive-chemoradiotherapy-for-oropharyngeal-cancer-in-a-patient-with-comorbid-sjgrens-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.92966","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,22]]}}}